DEXCOM INC (1DXCM.MI) Fundamental Analysis & Valuation

BIT:1DXCM • US2521311074

Current stock price

54 EUR
-7.19 (-11.75%)
Last:

This 1DXCM.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. 1DXCM.MI Profitability Analysis

1.1 Basic Checks

  • 1DXCM had positive earnings in the past year.
  • In the past year 1DXCM had a positive cash flow from operations.
  • In the past 5 years 1DXCM has always been profitable.
  • Each year in the past 5 years 1DXCM had a positive operating cash flow.
1DXCM.MI Yearly Net Income VS EBIT VS OCF VS FCF1DXCM.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

  • 1DXCM has a Return On Assets of 9.61%. This is amongst the best in the industry. 1DXCM outperforms 92.31% of its industry peers.
  • With an excellent Return On Equity value of 26.44%, 1DXCM belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
  • 1DXCM has a better Return On Invested Capital (15.72%) than 92.31% of its industry peers.
  • 1DXCM had an Average Return On Invested Capital over the past 3 years of 11.25%. This is in line with the industry average of 10.31%.
  • The last Return On Invested Capital (15.72%) for 1DXCM is above the 3 year average (11.25%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.61%
ROE 26.44%
ROIC 15.72%
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
1DXCM.MI Yearly ROA, ROE, ROIC1DXCM.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20 30

1.3 Margins

  • 1DXCM has a Profit Margin of 15.96%. This is amongst the best in the industry. 1DXCM outperforms 90.77% of its industry peers.
  • In the last couple of years the Profit Margin of 1DXCM has grown nicely.
  • With a decent Operating Margin value of 18.41%, 1DXCM is doing good in the industry, outperforming 73.85% of the companies in the same industry.
  • 1DXCM's Operating Margin has improved in the last couple of years.
  • 1DXCM has a Gross Margin of 60.20%. This is comparable to the rest of the industry: 1DXCM outperforms 60.00% of its industry peers.
  • 1DXCM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.41%
PM (TTM) 15.96%
GM 60.2%
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
1DXCM.MI Yearly Profit, Operating, Gross Margins1DXCM.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. 1DXCM.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1DXCM is creating some value.
  • Compared to 1 year ago, 1DXCM has less shares outstanding
  • 1DXCM has about the same amout of shares outstanding than it did 5 years ago.
  • The debt/assets ratio for 1DXCM has been reduced compared to a year ago.
1DXCM.MI Yearly Shares Outstanding1DXCM.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
1DXCM.MI Yearly Total Debt VS Total Assets1DXCM.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • 1DXCM has an Altman-Z score of 5.23. This indicates that 1DXCM is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 5.23, 1DXCM belongs to the best of the industry, outperforming 86.15% of the companies in the same industry.
  • 1DXCM has a debt to FCF ratio of 2.36. This is a good value and a sign of high solvency as 1DXCM would need 2.36 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 2.36, 1DXCM is doing good in the industry, outperforming 73.85% of the companies in the same industry.
  • A Debt/Equity ratio of 0.47 indicates that 1DXCM is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.47, 1DXCM perfoms like the industry average, outperforming 49.23% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 2.36
Altman-Z 5.23
ROIC/WACC1.64
WACC9.58%
1DXCM.MI Yearly LT Debt VS Equity VS FCF1DXCM.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • A Current Ratio of 1.56 indicates that 1DXCM should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.56, 1DXCM perfoms like the industry average, outperforming 47.69% of the companies in the same industry.
  • 1DXCM has a Quick Ratio of 1.38. This is a normal value and indicates that 1DXCM is financially healthy and should not expect problems in meeting its short term obligations.
  • 1DXCM has a better Quick ratio (1.38) than 67.69% of its industry peers.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.38
1DXCM.MI Yearly Current Assets VS Current Liabilites1DXCM.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. 1DXCM.MI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 26.67% over the past year.
  • The Earnings Per Share has been growing by 22.10% on average over the past years. This is a very strong growth
EPS 1Y (TTM)26.67%
EPS 3Y33.93%
EPS 5Y22.1%
EPS Q2Q%51.11%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13.12%

3.2 Future

  • Based on estimates for the next years, 1DXCM will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.26% on average per year.
  • 1DXCM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.21% yearly.
EPS Next Y20.81%
EPS Next 2Y20.72%
EPS Next 3Y21.95%
EPS Next 5Y19.26%
Revenue Next Year12.81%
Revenue Next 2Y12.84%
Revenue Next 3Y13.05%
Revenue Next 5Y12.21%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
1DXCM.MI Yearly Revenue VS Estimates1DXCM.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
1DXCM.MI Yearly EPS VS Estimates1DXCM.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

3

4. 1DXCM.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • 1DXCM is valuated quite expensively with a Price/Earnings ratio of 29.83.
  • The rest of the industry has a similar Price/Earnings ratio as 1DXCM.
  • When comparing the Price/Earnings ratio of 1DXCM to the average of the S&P500 Index (27.50), we can say 1DXCM is valued inline with the index average.
  • With a Price/Forward Earnings ratio of 24.70, 1DXCM is valued on the expensive side.
  • Based on the Price/Forward Earnings ratio, 1DXCM is valued a bit more expensive than 61.54% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of 1DXCM to the average of the S&P500 Index (22.62), we can say 1DXCM is valued inline with the index average.
Industry RankSector Rank
PE 29.83
Fwd PE 24.7
1DXCM.MI Price Earnings VS Forward Price Earnings1DXCM.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 1DXCM's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. 1DXCM is more expensive than 61.54% of the companies in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as 1DXCM.
Industry RankSector Rank
P/FCF 22.9
EV/EBITDA 24.14
1DXCM.MI Per share data1DXCM.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • 1DXCM has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as 1DXCM's earnings are expected to grow with 21.95% in the coming years.
PEG (NY)1.43
PEG (5Y)1.35
EPS Next 2Y20.72%
EPS Next 3Y21.95%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 1DXCM.MI Dividend Analysis

5.1 Amount

  • 1DXCM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

1DXCM.MI Fundamentals: All Metrics, Ratios and Statistics

DEXCOM INC

BIT:1DXCM (4/22/2026, 7:00:00 PM)

54

-7.19 (-11.75%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-12
Earnings (Next)04-29
Inst Owners100.29%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap20.78B
Revenue(TTM)N/A
Net Income(TTM)720.70M
Analysts84.32
Price Target74.94 (38.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.05%
Min EPS beat(2)5.32%
Max EPS beat(2)6.77%
EPS beat(4)2
Avg EPS beat(4)-0.91%
Min EPS beat(4)-11.66%
Max EPS beat(4)6.77%
EPS beat(8)6
Avg EPS beat(8)4.61%
EPS beat(12)10
Avg EPS beat(12)13.69%
EPS beat(16)11
Avg EPS beat(16)6.53%
Revenue beat(2)2
Avg Revenue beat(2)0.74%
Min Revenue beat(2)0.61%
Max Revenue beat(2)0.88%
Revenue beat(4)2
Avg Revenue beat(4)0.02%
Min Revenue beat(4)-1.2%
Max Revenue beat(4)0.88%
Revenue beat(8)2
Avg Revenue beat(8)-0.92%
Revenue beat(12)5
Avg Revenue beat(12)-0.38%
Revenue beat(16)6
Avg Revenue beat(16)-0.58%
PT rev (1m)0%
PT rev (3m)-15.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.29%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.24%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE 29.83
Fwd PE 24.7
P/S 5.39
P/FCF 22.9
P/OCF 16.79
P/B 8.92
P/tB 9.27
EV/EBITDA 24.14
EPS(TTM)1.81
EY3.35%
EPS(NY)2.19
Fwd EY4.05%
FCF(TTM)2.36
FCFY4.37%
OCF(TTM)3.22
OCFY5.95%
SpS10.03
BVpS6.05
TBVpS5.82
PEG (NY)1.43
PEG (5Y)1.35
Graham Number15.7009 (-70.92%)
Profitability
Industry RankSector Rank
ROA 9.61%
ROE 26.44%
ROCE 19.96%
ROIC 15.72%
ROICexc 77.75%
ROICexgc 88.6%
OM 18.41%
PM (TTM) 15.96%
GM 60.2%
FCFM 23.51%
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
ROICexc(3y)35.45%
ROICexc(5y)29.66%
ROICexgc(3y)40.94%
ROICexgc(5y)33.19%
ROCE(3y)14.28%
ROCE(5y)11.73%
ROICexgc growth 3Y55.18%
ROICexgc growth 5Y18.96%
ROICexc growth 3Y50.14%
ROICexc growth 5Y16.58%
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
F-Score5
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 2.36
Debt/EBITDA 1.2
Cap/Depr 158.02%
Cap/Sales 8.55%
Interest Coverage 250
Cash Conversion 134.63%
Profit Quality 147.34%
Current Ratio 1.56
Quick Ratio 1.38
Altman-Z 5.23
F-Score5
WACC9.58%
ROIC/WACC1.64
Cap/Depr(3y)175.34%
Cap/Depr(5y)240.83%
Cap/Sales(3y)9.32%
Cap/Sales(5y)10.84%
Profit Quality(3y)97.76%
Profit Quality(5y)73.64%
High Growth Momentum
Growth
EPS 1Y (TTM)26.67%
EPS 3Y33.93%
EPS 5Y22.1%
EPS Q2Q%51.11%
EPS Next Y20.81%
EPS Next 2Y20.72%
EPS Next 3Y21.95%
EPS Next 5Y19.26%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13.12%
Revenue Next Year12.81%
Revenue Next 2Y12.84%
Revenue Next 3Y13.05%
Revenue Next 5Y12.21%
EBIT growth 1Y28.95%
EBIT growth 3Y30.52%
EBIT growth 5Y33.11%
EBIT Next Year73.63%
EBIT Next 3Y36.37%
EBIT Next 5Y30.37%
FCF growth 1Y112.47%
FCF growth 3Y127.88%
FCF growth 5Y36.21%
OCF growth 1Y93.75%
OCF growth 3Y30.77%
OCF growth 5Y25.76%

DEXCOM INC / 1DXCM.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DEXCOM INC?

ChartMill assigns a fundamental rating of 6 / 10 to 1DXCM.MI.


What is the valuation status of DEXCOM INC (1DXCM.MI) stock?

ChartMill assigns a valuation rating of 2 / 10 to DEXCOM INC (1DXCM.MI). This can be considered as Overvalued.


How profitable is DEXCOM INC (1DXCM.MI) stock?

DEXCOM INC (1DXCM.MI) has a profitability rating of 8 / 10.


What are the PE and PB ratios of DEXCOM INC (1DXCM.MI) stock?

The Price/Earnings (PE) ratio for DEXCOM INC (1DXCM.MI) is 29.83 and the Price/Book (PB) ratio is 8.92.


Can you provide the expected EPS growth for 1DXCM stock?

The Earnings per Share (EPS) of DEXCOM INC (1DXCM.MI) is expected to grow by 20.81% in the next year.